A randomised comparative effectiveness trial of YOGa and strengthening exercise for knee osteoArthritis (YOGA Trial)
- Conditions
- OsteoarthritisMusculoskeletal - OsteoarthritisPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitation
- Registration Number
- ACTRN12621000066886
- Lead Sponsor
- niversity of Tasmania
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 126
1. Aged >/=40 years
2. Knee pain on most days for at least six months
3. VAS knee pain intensity of >/=40 mm in the last month.
4. Meet American College of Rheumatology (ACR) clinical criteria for the diagnosis of knee OA
5. Be willing to participate in a group yoga program or group strengthening exercise program three times per week for 12-weeks and can attend on the days/times of the week that scheduled classes are running.
A painDETECT score of more than 12 will be used to identify neuropathic pain.
1. Patients currently or in the past three months engaged in strengthening exercise or yoga program
2. Other forms of inflammatory arthritis (especially rheumatoid arthritis and gout).
3. A significant knee injury that required treatment within the last six months.
4. Arthroscopy or open surgery in the index knee in the last six months or planned in the next 6-8 months.
5. Injections of corticosteroids (last three months) or hyaluronic acid (last six months) in the index knee.
6. Pregnancy or breastfeeding.
7. Currently participating in any other drug/device/exercise clinical trial related to OA.
8. Presence of any serious medical illness or condition that may preclude a 24-week follow up.
9. Any condition that precludes safe participation in exercise (i.e. fails the safety for exercise clearance).
10. Unable to walk without a gait aid.
11. Inability to provide informed consent in English.
12. Plan to start an exercise or another new treatment for knee OA in the next six months.
13. Planned absences (e.g. trips away) of >2 weeks maximum during the 12-week period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method